August Biotech Catalyst


31-Jul-2018 17:07 PM



    The biotech sector performance for July for iShares Nasdaq Biotechnology ETF (IBB)  up +6.04%, and small-cap biotech Spdr S&P Biotech Etf (XBI) down -0.11%. The month starts out strong but for the last 5-day performance IBB  -1.33%, and XBI -2.72%.  The notable leaders in July for IBB performance were Celgene Corp (CELG) +13.50%, Allergan plc (AGN) +10.42%, and ILLumina Inc (ILMN) 16.07%

    Looking ahead to August, these are the U.S. Food and Drug Administration (FDA) Prescription Drug User Fee Act (PDUFA)  catalyst investors should keep on the watch list. Our calendar date here

  • Insmed Inc (INSM)
  • Pain Therapeutics Inc (PTIE)- PDUFA August 7. Back on June 26, the Advisory Committee of FDA voted 14-3 against approval of REMOXY ER
  • Paratek Pharmaceuticals Inc (PRTK)
  • Alnylam Pharmaceuticals Inc (ALNY)
  • Regeneron Pharmaceuticals Inc (REGN)
  • Amicus Therapeutics Inc (FOLD)
  • Agios Pharmaceuticals Inc (AGIO)
  • Vascular Biogenics Ltd (VBLT)
  • Kala Pharmaceuticals Inc (KALA)
  • Tetraphrase Pharmaceuticals Inc (TTPH)
  • Akcea Therapeutics Inc (AKCA) and Ionis Pharmaceuticals Inc (IONS)

    For investors and traders watchlist for biotech upcoming clinical data results. Here is the full Q3 list upcoming biotech data

Biotech possible data release in August for these names:

  • Alnylam Pharmaceuticals Inc (ALNY)
  • AnaptysBio (ANAB)
  • Athene Inc (ATNX)
  • BeyondSpring Inc (BYSI)
  • Bellerophon Therapeutics Inc (BLPH)
  • Galectin Therapeutics Inc (GALT)
  • Marinus Pharmaceuticals Inc (MRNS)
  • Spark Therapeutics Inc (ONCE)
  • Obseva SA (OBSV)
  • Urogen Pharma Ltd (URGN)

A unique mathematics formula with 83% accuracy predict clinical data

Contact us:

Twitter: @BiotechMoney18






Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.